USP Compounding Chapters: Understanding the Latest Revisions
Home Study Webinar
$20 Activity Fee – available through August 24, 2026.
On November 1, 2022, United States Pharmacopeia (USP) published updates to USP General Chapters <795> and <797> on compounding nonsterile and sterile preparations. The revisions to the chapters, including updates to the beyond-use dates (BUDs), reflect advancements in science and clinical practice, clarify topics that were not consistently understood, and incorporate input from stakeholder engagements and comments received during the public comment period. These chapters will become official on November 1, 2023, to allow for increased flexibility and engagement for adoption. This webinar will include a brief presentation and then provide an opportunity for attendees to hear questions regarding the compounding General Chapter revisions answered by members of the USP Compounding Expert Committee.
This home study webinar is a recording of the live activity that was held on September 14, 2023.
How to Access the Home Study Webinar and Earn CPE
The home study webinar is eligible for Accreditation Council for Pharmacy Education-accredited continuing pharmacy education (CPE) credit. More details regarding the presentation, CPE activity credits, and browser requirements can be found in the CPE Activity Information Guide.
Follow the steps below to access the home study webinar and claim CPE credit:
- Log in to your NABP e-Profile and select the Continuing Education Activities tile to purchase this activity and obtain the access code and instructions.
- Log in to NABP’s CPE Submission Site and select the “Home Study CPE” tab.
- If you do not have a log in for Learner Community, you will need to create an account.
- Enter the access code provided in your confirmation email and click “Redeem Code.”
- Enter only one code at a time.
- View the recording, complete the activity in its entirety, including watching the full video, and pass the post-test. Once completed, the Credit section will unlock.
- Select the appropriate credit (pharmacy or pharmacy technician), enter your NABP e-Profile ID and date of birth, and click the “claim” button to earn credit.
Claims must be submitted within 60 days from the date you opened the activity.
Presenters
Brenda Jensen, CPhT, CNMT, MBA, is the current chair of the USP Compounding Expert Committee and previously was a member of the 2015-2020 Compounding Expert Committee. She also participates on the Radiopharmaceutical Standards Expert Panel. Jensen is an independent consultant and owner of Compounding Consultants, LLC. She helps facilities improve compounding quality and safety by providing gap analyses, on-site training, and customized standard operating procedures. Her previous experience includes sterile and nonsterile compounding in hospital, clinic, and community pharmacy settings. Her sterile compounding experience includes oncology, nuclear, and high-risk level compounding. Jensen is a member of multiple pharmacy organizations, president of the American College of Veterinary Pharmacists, and a member of the American Pharmacists Association (APhA) House of Delegates.
Gus Bassani, PharmD, currently serves as chief scientific officer for PCCA, a Houston-based supplier of active pharmaceutical ingredients and excipients and formulation and drug information consulting to pharmacies, health care institutions, and outsourcing facilities. He has been with PCCA since 2002. Before that, he was a formulation pharmacist in the product development lab of a veterinary pharmaceutical company. Dr Bassani has worked in multiple pharmacy practice settings in Alaska, Iowa, and Kansas, and has taught extemporaneous compounding principles to pharmacy students in Drake University’s Pharmaceutics Laboratory course. He received his doctor of pharmacy degree from Drake University College of Pharmacy and Health Sciences. He is a member of the 2020-2025 USP Compounding Expert Committee and chairs the <795> Subcommittee. Previously, he was a member of the 2010-2015 and 2015-2020 USP Compounding Expert Committees. Gus served on the 2012-2014 Drake University College of Pharmacy and Health Sciences National Advisory Council and is a member of the APhA, the Alliance for Pharmacy Compounding, the American Association of Pharmaceutical Scientists, and the National Community Pharmacists Association.
Connie Sullivan, BS Pharm, is the president and chief executive officer of the National Home Infusion Association (NHIA). Sullivan has over 25 years of home infusion industry leadership, management, and clinical practice experience. She is responsible for NHIA’s legislative and regulatory advocacy initiatives and developing resources that support the infusion industry to foster innovation and promote the delivery of high-quality patient care. Sullivan also oversees the National Home Infusion Foundation, a not-for-profit subsidiary of the association devoted to research, leadership development, and education programs. She is a member of the 2020-2025 USP Compounding Expert Committee and chairs the <797> Subcommittee. Before joining NHIA, Sullivan served for 15 years as the national director of infusion for a national home health and skilled nursing provider. She earned her bachelor’s degree in pharmacy from The Ohio State University College of Pharmacy in 1994.